Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Cash Flows

v3.6.0.2
Consolidated Statements of Cash Flows - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2016
Dec. 26, 2015
Dec. 27, 2014
Statement of Cash Flows [Abstract]      
Cash and cash equivalents, beginning of period $ 15,308 $ 2,561 $ 5,674
Cash flows provided by (used for) operating activities:      
Net income 10,316 11,420 11,704
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation 6,266 7,821 7,380
Share-based compensation 1,444 1,305 1,148
Excess tax benefit from share-based payment arrangements (121) (159) (122)
Restructuring and other charges 1,886 354 295
Amortization of intangibles 1,524 890 1,169
(Gains) losses on equity investments, net (432) (263) (354)
Deferred taxes 257 (1,270) (703)
Changes in assets and liabilities:1      
Accounts receivable 65 (355) (861)
Inventories 119 (764) (98)
Accounts payable 182 (312) (249)
Accrued compensation and benefits (1,595) (711) 4
Income taxes payable and receivable 1,382 386 (286)
Other assets and liabilities 515 675 1,391
Total adjustments 11,492 7,597 8,714
Net cash provided by operating activities 21,808 19,017 20,418
Cash flows provided by (used for) investing activities:      
Additions to property, plant and equipment (9,625) (7,326) (10,105)
Acquisitions, net of cash acquired (15,470) (913) (934)
Purchases of available-for-sale investments (9,269) (8,259) (7,007)
Sales of available-for-sale investments 3,852 2,090 1,227
Maturities of available-for-sale investments 5,654 6,168 8,944
Purchases of trading assets (12,237) (11,485) (14,397)
Maturities and sales of trading assets 10,907 13,372 13,165
Investments in loans receivable and reverse repurchase agreements (223) (2,550) (150)
Collection of loans receivable and reverse repurchase agreements 911 2,116 117
Investments in non-marketable equity investments (963) (2,011) (1,377)
Other investing 646 615 612
Net cash used for investing activities (25,817) (8,183) (9,905)
Cash flows provided by (used for) financing activities:      
Increase (decrease) in short-term debt, net (15) (474) 235
Excess tax benefit from share-based payment arrangements 121 159 122
Issuance of long-term debt, net of issuance costs 2,734 9,476 0
Repayments of Long-term Debt (1,500) 0 0
Proceeds from sales of common stock through employee equity incentive plans 1,108 866 1,660
Repurchase of common stock (2,587) (3,001) (10,792)
Restricted stock unit withholdings (464) (442) (332)
Payment of dividends to stockholders (4,925) (4,556) (4,409)
Collateral associated with repurchase of common stock 0 325 (325)
Increase (decrease) in liability due to collateral associated with repurchase of common stock 0 (325) 325
Other financing (211) (116) (95)
Net cash provided by (used for) financing activities (5,739) 1,912 (13,611)
Effect of exchange rate fluctuations on cash and cash equivalents 0 1 (15)
Net increase (decrease) in cash and cash equivalents (9,748) 12,747 (3,113)
Cash and cash equivalents, end of period 5,560 15,308 2,561
Supplemental disclosures:      
Acquisitions of property, plant, and equipment included in accounts payable and accrued liabilities 979 392 985
Interest, net of capitalized interest and interest rate swap payments/receipts 682 186 167
Income taxes, net of refunds $ 877 $ 3,439 $ 4,639